N. Belmecheri

Peripheral T-cell lymphomas: analysis of histology, staging and response to treatment of 208 cases at a single institution

R. Bouabdallah, L. Xerri, B. Chetaille, 2013, Leukemia & lymphoma.

JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab

R. Bouabdallah, D. Coso, J. Rey, 2007, Haematologica.

Rituximab combined with chemotherapy for lymphoma during pregnancy.

R. Bouabdallah, D. Coso, J. Rey, 2009, Leukemia research.

A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma.

R. Bouabdallah, D. Coso, N. Vey, 2023, Hematology.

Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study

P. Feugier, M. André, E. Durot, 2021, Blood.

A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma

R. Bouabdallah, D. Coso, N. Vey, 2023, Hematology.